CERRITO MARIA GRAZIA

Ruolo:

Tecnico - amministrativo

Afferenza:

E-mail:

Telefono:

0264488339

Stanza:

U8, Piano: IV, Stanza: L4.6B
Via Cadore, 48 - 20900 MONZA

Sala, L., Cirillo, G., Riva, G., Romano, G., Giussani, C., Cialdella, A., et al. (2019). Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype. FRONTIERS IN MOLECULAR NEUROSCIENCE, 12. Dettaglio
Giordano, F., Vaira, V., Cortinovis, D., Bonomo, S., Goedmakers, J., Brena, F., et al. (2019). p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 38(1). Dettaglio
Basile, D., Gerratana, L., Buonadonna, A., Garattini, S., Perin, T., Grassilli, E., et al. (2019). Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer. CANCERS, 11(6). Dettaglio
Lavitrano, M., Ianzano, L., Bonomo, S., Cialdella, A., Cerrito, M., Pisano, F., et al. (2019). BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers. JOURNAL OF PATHOLOGY. Dettaglio
Cerrito, M., De Giorgi, M., Pelizzoni, D., Bonomo, S., Digiacomo, N., Scagliotti, A., et al. (2018). Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. ONCOTARGET, 9(44), 27448-27459. Dettaglio

Futuri studenti